FIELD: medicine, immunology, narcology.
SUBSTANCE: invention can be used for treatment of narcomania, intoxication with different poisons in industry and in homes, in technogenic catastrophe and so on. Synthetic immunogen represents conjugate as the natural or artificial protein (egg albumin or human gamma-globulin, or bacterial toxins) as a carrier and haptene - narcotic or psychotropic compound taken among the following groups of low-molecular compounds: aromatic propaneamines or isoquinolines, or diphenylmethanes, or indoleamines, or derivatives of barbituric acid, or derivatives of substituted piperidines. Conjugate is modified with an immunocompetent polyelectrolyte - polyoxidonium in the ratio, weight %: conjugate : polyoxidonium = 1:(1.5-5.0). The advantage of invention involves the high immunological activity, reduced doses and treatment periods.
EFFECT: valuable properties of immunogen.
1 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
SYNTHETIC IMMUNOGEN FOR PROTECTION AGAINST TOXIC ACTION OF NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2012 |
|
RU2526807C2 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2643329C1 |
SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2635517C1 |
VACCINE AGAINST HYPERTENSION | 2004 |
|
RU2259847C1 |
METHOD FOR TREATING OPIUM NARCOMANIA | 2005 |
|
RU2290947C1 |
IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
MONOCLONAL ANTIBODY 3K11 TO MORPHINE DERIVATIVES | 2018 |
|
RU2702002C1 |
MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-K11B, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2020 |
|
RU2745374C1 |
METHOD FOR TREATING THE CASES OF DRUG ADDICTION | 2003 |
|
RU2288717C2 |
METHOD FOR DETERMINING NARCOTIC DRUGS IN HUMAN ORAL FLUID BY IMMUNOCHROMATOGRAPHY | 2010 |
|
RU2746467C1 |
Authors
Dates
2004-09-20—Published
2003-09-15—Filed